COLUMBIA, Md., May 08, 2019 (GLOBE NEWSWIRE) — W. R. Grace & Co. (NYSE: GRA) today announced that its Board of Directors elected William C. Dockman as Senior Vice President and Chief Financial Officer, effective immediately. Mr. Dockman had been serving as interim CFO since May 2018. William C. Dockman is appointed Senior Vice President and Chief Financial Officer of... Read more
Basel, 08 May 2019 Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting New analyses show the effect of OCREVUS on reducing the risk of disability progression is associated with exposure and lower B-cell levels Long-term data in... Read more
May 8, 2019 https://www.coherent.com/assets_api_inc/pr_investor_staging/Coherent_Inc_Announces_Changes_to_the_Board_of_Directors_2019.pdf Read more
CHELMSFORD, Mass., May 7, 2019 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in three upcoming investor conferences: Bank of America Merrill Lynch Health Care Conference at the Encore Hotel in Las Vegas, Nevada on May 16, 2019 at 8:00 a.m. PDT (11:00 a.m. EDT). UBS Global Healthcare Conference at... Read more
WALTHAM, Mass., May 7, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the... Read more
Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 14, 2019 WALTHAM, Mass., May 7, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America... Read more
Basel, 07 May 2019 Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting In the dose-finding Part 1 of FIREFISH, infants with Type 1 spinal muscular atrophy survive and achieve key milestones beyond those expected in the natural history of the disease New... Read more
QIAGEN to conduct an additional up to $100 million share repurchase program Venlo, The Netherlands, May 6, 2019 – QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has today passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 19, 2018, and to purchase shares in the... Read more
QIAGEN delivers on Q1 2019 outlook Net sales of $348.7 million (+1.5% actual, +6.1% at constant exchange rates, or CER vs. ~5-6% CER outlook) Diluted EPS of $0.13; adj. EPS of $0.27 ($0.28 CER vs. ~$0.26-0.27 CER outlook) Sample to Insight portfolio fueled by dynamic innovation and disruptive solutions FDA approval of new therascreen companion... Read more
MENLO PARK, Calif., May 03, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached.During the first quarter of 2019, the Company announced that it commenced its Early Access Program of the Sequel II System and the SMRT Cell 8M... Read more